Carboxymethylcellulose sodium

羧甲基纤维素钠

Report date: 2026/03/09 20:02:04
NME

Base Information

Drug NameCarboxymethylcellulose sodium
Drug Alias NameCarmellose sodium开仕CelluviscBulkose潇莱威
ClassificationSmall molecules
Mechanisms of ActionUndefined mechanism
TargetsNot applicable
Therapy Area/IndicationsDiabetic FootDry Eye SyndromesEye Pain +[5] 
Global Approved IndicationsEye Pain
Approved Indications in ChinaEye Pain
Original Approved Country/TerritoryMainland China
Original Approved Date1999/09/17
Country/TerritoryBelgiumCanadaUnited States +[13] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesAllergan PlcEisai Co LtdAlfresa Pharma
China Registration ClassN/A

Develop Information

Active CompaniesAllergan Inc
Inactive CompaniesKorea Institute Of Oriental MedicineAllergan PlcUniversity Of Chile +[4] 
Active IndicationsEye Pain
Inactive IndicationsDiabetic FootDry Eye SyndromesXerophthalmia +[4] 

Other Information

ATC CodeS01XA20
Related LinksWikipediaDrugBankKEGG